REVELATION BIOSCIENCES, INC.
Clinical-stage biopharma developing immunologic therapies to prevent and treat disease.
REVB | US
Overview
Corporate Details
- ISIN(s):
- US7164211028 (+4 more)
- LEI:
- Country:
- United States of America
- Address:
- 4660 LAJOLLA VILLAGE DRIVE, 92122 SAN DIEGO
- Website:
- https://www.revbiosciences.com/
Description
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing immunologic-based therapies for the prevention and treatment of disease. The company's core strategy involves rebalancing inflammation and harnessing the innate immune system to optimize health. Its lead product candidate, Gemini, is an intravenously administered, proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD®). Gemini is designed to reprogram the innate immune system to respond to stressors like trauma and infection in an attenuated manner, thereby reducing inflammation-associated damage. The company is evaluating Gemini for various applications, including the prevention of post-surgical infections and acute kidney injury.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all REVELATION BIOSCIENCES, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for REVELATION BIOSCIENCES, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for REVELATION BIOSCIENCES, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
